Skip to content

Tucatin

Generic Name
Tucatinib
Therapeutic Area
Oncology
Therapeutic Class
Antineoplastics and protein kinase inhibitors
Dosage Form
Tablets
Strength
150 mg
Pack Size
30's
Registration Number
129025

Overview

Tucatinib is an oral, highly selective HER2-targeted tyrosine kinase inhibitor. It blocks HER2-mediated signalling pathways involved in cancer cell growth and proliferation. It is used in combination with other therapies for eligible patients with HER2-positive advanced or metastatic breast cancer.

Indication

The treatment of specific types of HER2-positive breast cancer and HER2-positive colorectal cancer.